Ionis Pharmaceuticals Inc. Common Stock vs National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares trades at $79.82 (market cap $78.25B). The key difference: National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares is far larger — about 11.1× Ionis Pharmaceuticals Inc. Common Stock's market cap, and National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares pays a 4.14% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IONS | NGG | |
|---|---|---|
Market Cap | $7.04B | $78.25B |
Volume | 2,977,440 | 1,070,031 |
Sector | Health | Utilities |
52-Week High | $86.50 | $93.93 |
52-Week Low | $42.38 | $73.54 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $6.60B | $136.28B |
Dividend Yield | — | 4.14% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
National Grid (NGG) trades at $78.23, up 1.44% on the day, with a market cap of approximately $48.3 billion. The stock shows stable technicals near its consensus price target of $79.25. Fundamentally, it maintains strong profitability with an 18.32% net income margin and has beaten EPS estimates in recent quarters. Recent news highlights institutional buying and a focus on grid innovation, including AI adoption.
Outlook is cautiously positive with upside to the high target of $85.50, supported by earnings momentum and strategic investments. Risks include high debt levels and regulatory pressures. Analyst consensus leans buy (55%), but hold ratings reflect concerns over capital intensity and macroeconomic sensitivity.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →National Grid plc is a British utility company that owns and operates electricity and gas transmission networks in Great Britain, and through its US Regulated business, operates electricity and gas transmission and distribution networks serving customers in New York and Massachusetts. Its shares trade on the NYSE as American Depositary Shares under the ticker NGG.
Read more on NGG →